NIAGEN BIOSCIENCE, INC. Revenue from Related Parties
NIAGEN BIOSCIENCE, INC. (NAGE) reported Revenue from Related Parties of $2.60 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2022-11-02
- NIAGEN BIOSCIENCE, INC. revenue from related parties for the quarter ending 2022-09-30 was $2.60M, a 0.00% change year-over-year.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for the quarter ending 2022-06-30 was $1.50M, a 48.28% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for the quarter ending 2022-03-31 was $2.60M, a 62.50% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for the quarter ending 2021-12-31 was $2.20M, a 4.76% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for fiscal 2021 was $9.30M, a 0.00% change from fiscal 2020.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for fiscal 2020 was $9.30M, a 27.40% increase from fiscal 2019.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for fiscal 2019 was $7.30M, a 121.21% increase from fiscal 2018.
- NIAGEN BIOSCIENCE, INC. revenue from related parties for fiscal 2018 was $3.30M, a 19.51% decline from fiscal 2017.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2022-09-30 | $2.60M 10-Q · filed 2022-11-02 | $4.10M derived: sum of 2 quarters · filed 2022-11-02 | $6.70M 10-Q · filed 2022-11-02 | $8.90M derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-06-30 | $1.50M 10-Q · filed 2022-08-10 | $4.10M 10-Q · filed 2022-08-10 | $6.30M derived: sum of 3 quarters · filed 2022-08-10 | $8.90M derived: sum of 4 quarters · filed 2022-11-02 |
| 2022-03-31 | $2.60M 10-Q · filed 2022-05-12 | $4.80M derived: sum of 2 quarters · filed 2022-05-12 | $7.40M derived: sum of 3 quarters · filed 2022-11-02 | $10.30M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $4.80M derived: sum of 2 quarters · filed 2022-11-02 | $7.70M derived: sum of 3 quarters · filed 2022-11-02 | $9.30M 10-K · filed 2022-03-14 |
| 2021-09-30 | $2.60M 10-Q · filed 2022-11-02 | $5.50M derived: sum of 2 quarters · filed 2022-11-02 | $7.10M 10-Q · filed 2022-11-02 | $9.20M derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $2.90M 10-Q · filed 2022-08-10 | $4.50M 10-Q · filed 2022-08-10 | $6.60M derived: sum of 3 quarters · filed 2022-08-10 | $9.10M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $1.60M 10-Q · filed 2022-05-12 | $3.70M derived: sum of 2 quarters · filed 2022-05-12 | $6.20M derived: sum of 3 quarters · filed 2022-05-12 | $9.10M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $4.60M derived: sum of 2 quarters · filed 2022-03-14 | $7.50M derived: sum of 3 quarters · filed 2022-03-14 | $9.30M 10-K · filed 2022-03-14 |
| 2020-09-30 | $2.50M 10-Q · filed 2021-11-03 | $5.40M derived: sum of 2 quarters · filed 2021-11-03 | $7.20M 10-Q · filed 2021-11-03 | $9.00M derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | $2.90M 10-Q · filed 2021-08-03 | $4.70M 10-Q · filed 2021-08-03 | $6.50M derived: sum of 3 quarters · filed 2021-08-03 | $8.80M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $1.80M 10-Q · filed 2020-05-18 | $3.60M derived: sum of 2 quarters · filed 2021-03-12 | $5.90M derived: sum of 3 quarters · filed 2021-03-12 | $7.80M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $4.10M derived: sum of 2 quarters · filed 2021-03-12 | $6.00M derived: sum of 3 quarters · filed 2021-03-12 | $7.30M 10-K · filed 2021-03-12 |
| 2019-09-30 | $2.30M 10-Q · filed 2020-11-04 | $4.20M derived: sum of 2 quarters · filed 2020-11-04 | $5.50M 10-Q · filed 2020-11-04 | $6.60M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $1.90M 10-Q · filed 2020-08-06 | $3.20M 10-Q · filed 2020-08-06 | $4.30M derived: sum of 3 quarters · filed 2020-08-06 | $5.00M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $1.30M 10-Q · filed 2020-05-18 | $2.40M derived: sum of 2 quarters · filed 2020-05-18 | $3.10M derived: sum of 3 quarters · filed 2020-05-18 | $3.40M derived: sum of 4 quarters · filed 2020-05-18 |
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.80M derived: sum of 2 quarters · filed 2020-03-10 | $2.10M derived: sum of 3 quarters · filed 2020-03-10 | $3.30M 10-K · filed 2020-03-10 |
| 2018-09-30 | $700.00K 10-Q · filed 2019-11-12 | $1.00M derived: sum of 2 quarters · filed 2019-11-12 | $2.20M 10-Q · filed 2019-11-12 | $4.00M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $300.00K 10-Q · filed 2019-08-07 | $1.50M 10-Q · filed 2019-08-07 | $3.30M derived: sum of 3 quarters · filed 2019-08-07 | $5.60M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $1.20M 10-Q · filed 2019-05-09 | $3.00M derived: sum of 2 quarters · filed 2019-05-09 | $5.30M derived: sum of 3 quarters · filed 2019-05-09 | $5.30M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $4.10M derived: sum of 2 quarters · filed 2019-03-07 | $4.10M derived: sum of 3 quarters · filed 2019-03-07 | $4.10M 10-K · filed 2019-03-07 |
| 2017-09-30 | $2.30M 10-Q · filed 2018-11-07 | $2.30M derived: sum of 2 quarters · filed 2018-11-07 | $2.30M 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |